Doctors Are Testing a Catheter-Based Technique for Severe, Hard-to-Treat Back Pain
A small early-stage study presented this month explored delivering pain medication directly into the blood vessels that feed a painful section of the spine. Here is what the preliminary findings suggest, and why any new approach like this still takes years of further study before it becomes standard care.
Key takeaways
- Researchers presented an early pilot study on a catheter-guided technique that infuses medication directly into arteries near a painful spinal segment, adapting a method borrowed from stroke care.
- The pilot involved only six patients with severe, treatment-resistant thoracolumbar pain, so the findings are preliminary and far from proof the approach works broadly.
- A separate, much larger 2026 review of spinal manipulation reinforces that conservative, non-surgical care remains a reasonable starting point for most people with chronic back pain.
- Las Vegas Spine & Disc offers this roundup for general awareness only; it is not medical advice, and no treatment mentioned here should be assumed to guarantee any particular outcome.
Figures reflect a small, early-stage pilot study and a separate large evidence review; neither should be read as a guarantee of results for any individual.
A stroke-care technique aimed at the spine
Every so often, a research team borrows a tool from one corner of medicine and points it somewhere new. That is essentially what a group from the University of Texas Medical Branch did with a technique presented at the Society of NeuroInterventional Surgery's annual meeting this July. Instead of using catheter-guided artery access to treat a stroke, the team used it to reach the small blood vessels that supply a painful section of the lower and mid back.
The procedure works by threading a thin catheter through the femoral artery, in the upper leg, up toward the vessels that feed the affected spinal segment. Once positioned, the doctors infused a mix of a numbing agent and an anti-inflammatory steroid directly into that local blood supply, rather than relying on pain medication that has to circulate through the entire body first.
The idea behind targeting the vessels themselves, rather than injecting directly into a joint or nerve root the way a traditional nerve block does, is to reach inflamed tissue that may be difficult to access with a needle alone. It is a novel enough idea that the research team describes it as preliminary work, not a finished treatment.
What the early results showed, and why the sample size matters
The pilot group was small: six patients whose back pain had not responded well to more conventional care. Before the procedure, patients rated their pain at an average of about 9.5 out of 10. Immediately afterward, that average dropped to zero, and researchers reported that pain relief was largely sustained at a three-month follow-up check.
Two of the six patients were able to stop using opioid pain medication entirely during their hospital stay, and four of the six said they could finally tolerate physical therapy sessions that had previously been too painful to complete. The lead investigator, Dr. Matias Costa, was quoted saying the findings suggest this kind of vascular-based therapy could someday play a role in easing pain, supporting function, and reducing reliance on opioids.
That said, six patients is a very small group, and there was no comparison group receiving a placebo procedure in this initial round. Researchers themselves describe this as early-stage work that needs larger, controlled follow-up studies before anyone can say how well it holds up, who it helps most, or how it compares with existing options like nerve blocks or radiofrequency ablation.
How this fits alongside more established, conservative options
It is worth putting an experimental six-patient pilot in context. A much larger analysis published this year, a Cochrane review pooling 76 randomized trials and nearly 12,000 participants, looked at spinal manipulation for chronic low back pain. It found modest pain and function benefits compared with a sham treatment, larger benefits compared with no treatment at all, and roughly similar results compared with other conservative care such as guided exercise.
The review's authors were candid that the overall certainty of evidence remains low to very low, and they called for better-designed studies going forward, echoing the same cautious tone researchers are taking with the new catheter-based technique. Both threads of research point to the same broader lesson: back pain research is advancing on many fronts at once, from vascular-targeted infusions to refined manual therapy, but very few approaches are backed by large, high-certainty trials yet.
For most people dealing with everyday back or neck discomfort, that means conservative, well-studied options such as physical therapy, targeted exercise, posture adjustments, and non-invasive care remain a sensible starting point, with more invasive or experimental interventions typically reserved for cases that have not responded to those first steps.
What this could mean down the road, with real caveats
If larger trials eventually confirm these early signals, a catheter-based infusion technique could one day become another tool available to a small subset of patients with severe, treatment-resistant spinal pain who have exhausted more conservative options. But that is a big if, and it is many steps away from being offered as a routine clinic procedure.
In the meantime, this kind of study is a useful reminder of how much active research is happening around non-surgical and minimally invasive back pain care. New techniques often take years to move from a six-patient pilot to something a physician might discuss as an established option, and most never make that full journey at all.
As always, anyone dealing with persistent or severe back pain should talk with a qualified clinician about which evaluation and care options make sense for their specific situation, rather than pursuing an experimental procedure based on early headlines alone.
Non-surgical approaches people commonly discuss with their care team
Back pain care spans a wide spectrum, from simple daily habits to more advanced interventional options. This is a general informational overview, not a recommendation for any specific person; what makes sense depends on your history, imaging, and a clinician's evaluation.
- Targeted physical therapy: Guided exercise programs built around strengthening the core and improving mobility are often a first-line recommendation for chronic back pain.
- Posture and ergonomic changes: Adjusting how you sit, stand, and work, including monitor height and chair support, can reduce strain that builds up over a long day.
- Nerve blocks and epidural injections: These deliver medication near an irritated nerve root and are sometimes used as a bridge to help patients participate more comfortably in active rehabilitation.
- Radiofrequency ablation: This minimally invasive option uses targeted heat to interrupt specific pain signals and is discussed for certain cases of persistent facet or nerve-related pain.
- Spinal manipulation or chiropractic care: Reviewed extensively in the 2026 Cochrane analysis, manipulation shows modest benefit for many patients compared with doing nothing, though effects vary by individual.
- Mindfulness and stress-focused approaches: Because chronic pain and stress often interact, some clinicians incorporate mindfulness-based strategies alongside physical treatment plans.
- Regenerative or biologic injections: Options such as PRP are being studied for certain disc-related conditions, though research on long-term effectiveness is still developing.
Frequently Asked Questions
What exactly is this new catheter-based back pain technique?
It is an experimental procedure where doctors guide a thin catheter through an artery in the leg up toward blood vessels supplying a painful section of the spine, then infuse a numbing agent and anti-inflammatory medication directly into that local blood supply. It was described in a small pilot study presented in July 2026.
Is this treatment available to patients right now?
No. The technique was tested in only six patients as part of early-stage research presented at a medical conference. It has not been established as a standard treatment, and much larger studies are needed before that could change.
How is this different from a standard nerve block?
A traditional nerve block typically involves injecting medication near a specific nerve root. This experimental approach instead targets the small arteries feeding a broader area of tissue, aiming to reach inflammation that a direct nerve injection might not reach as effectively. Researchers themselves note this distinction is still being studied.
Does spinal manipulation actually help chronic back pain?
A large 2026 Cochrane review of 76 trials found that spinal manipulation offers modest pain and function benefits compared with a placebo treatment, and benefits roughly similar to other conservative options like exercise, though the overall certainty of evidence remains low.
Sources
- Experimental neurointerventional technique shows promise for severe back pain — News-Medical
- Back Pain Relief 2026: What the Cochrane Evidence Says — Vanguard Chiropractic